Are Neonatal Neurobehavior Scores at Hospital Discharge among Newborns with Neonatal Opioid Withdrawal Syndrome Associated with the Duration of Pharmacologic Treatment?

Abbot R.. Laptook, Women & Infants Hospital of Rhode Island, North Kingstown, RI, United States; Adam Czynski, Connecticut Children's Medical Center, East Greenwich, RI, United States; Rouba A.. Chahine, RTI International, RTP, NC, United States; barry lester, The Warren Alpert Medical School of Brown University, east greenwich, RI, United States; Lynne Andreozzi, Women & Infants Hospital of Rhode Island, Providence, RI, United States; Clare Campbell Asher, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Gwenevere White, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Tara Venable, University of Arkansas for Medical Sciences College of Medicine, Little Rock, AR, United States; Kristen L. Benninger, Nationwide Children's Hospital, Columbus, OH, United States; Sofia Markee, University of New Mexico Hospital, Albuquerque, NM, United States; Tanner Wright, USF Health Morsani College of Medicine, Tampa, FL, United States; Brooke Yancey-Ward, University of Arkansas for Medical Sciences, Little Rock, AR, United States; for the Eunice Kennedy Shriver NICHD Neonatal Research Network and the, RTI International, Durham, NC, United States